Treatment outcome in dually HIV-1 and HIV-2 coinfected patients living in Spain
Autor:
Requena, S.
; Caballero, Estrella
; Lozano, A. B.
; Ríos-Villegas, María
; Benito, Rafael
; Rojo, Silvia
; Cabezas, Teresa
; Macià, María
; Nieto, María del
; Soriano, Vicente
; Mendoza, Carmen de
Fecha:
15/11/2019Palabra clave:
Revista / editorial:
AIDSTipo de Ítem:
Articulo Revista IndexadaResumen:
Background: Whereas HIV-1 has spread globally, HIV-2 is mainly found in West Africa where dual HIV-1/HIV-2 coinfection is nowadays uncommon. Herein, we report the rate, main characteristics, and treatment outcomes of all dually infected patients living in Spain.Methods:We identified retrospectively all persons coinfected with HIV-1 recorded at the Spanish HIV-2 registry. Dual infection had been confirmed using PCR in plasma and/or cells, and/or using discriminatory serological tests.Results:From a total of 373 individuals with HIV-2 recorded at the Spanish registry, 34 (9.1%) were coinfected with HIV-1. Compared with HIV-2 monoinfected persons, dually infected patients were more often male (67.6%), presented with lower median CD4+ cell counts (204 cells/μl), and had developed more frequently AIDS events (26.5%). Although 61.7% came from West Africa, 6 (17.6%) were native Spaniards. HIV-1 non-B subtypes were recognized in 75% of coinfected patients, being the most prevalent CRF02-AG. At baseline, 45% of dually infected patients had undetectable plasma HIV-2 RNA. After a median follow-up of 32 (13-48) months on antiretroviral therapy, dually infected patients achieved undetectable viremia in 85% for HIV-1, in 80% for HIV-2; and in 70% for both viruses. Median CD4+ cell counts reached up to 418 cells/μl.Conclusion:Roughly 9% of individuals with HIV-2 infection living in Spain are coinfected with HIV-1. Overall, 70% of dually infected patients achieved viral suppression for both viruses under antiretroviral therapy. Given the relatively large population of West Africans living in Spain and the continuous migration flow from HIV-2 endemic areas, HIV-1/HIV-2 coinfection should always be excluded at first diagnosis in all HIV-seroreactive persons.
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
Año |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
2020 |
2021 |
2022 |
2023 |
2024 |
Vistas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
150 |
28 |
49 |
49 |
94 |
Descargas |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Short Communication: Impact of COVID-19 on Case Reporting for HTLV and HIV-2 in Spain
de Mendoza, Carmen; Caballero, Estrella; Eirós, José M.; Rojo, Silvia; Benito, Rafael; Soriano, Vicente (Mary Ann Liebert Inc., 2021)The medical demand imposed by COVID-19 has distracted proper care of other illnesses. Herein, we report the impact on new diagnoses of HTLV-1, HTLV-2, and HIV-2 in Spain, where these infections are mostly driven by immigration ... -
Antiretroviral Therapy for HIV-2 Infection in Non-Endemic Regions
Mendoza, Carmen de; Lozano, A. B.; Caballero, Estrella; Cabezas, Teresa; Ramos, José M.; Soriano, Vicente ; Spanish HIV-2 Network (AIDS Reviews, 01/2020)Human immunodeficiency virus type 2 (HIV-2) was isolated in AIDS patients in 1986. Around 1-2 million people are infected worldwide. The virus is less transmissible than HIV-1, being sexual contacts the most frequent route ... -
HIV co-infection in HTLV-1 carriers in Spain
Mendoza, Carmen de; Caballero, Estrella; Aguilera, Antonio; Benito, Rafael; Maciá, Dolores; García-Costa, Juan; Soriano, Vicente ; Corral, Octavio Jorge ; Gómez-Gallego, Felix ; ...et al.; Morano, Luis (Virus Research, 06/2019)Background: Human retroviruses HIV and HTLV share transmission routes. HIV widely spread in Spain during the 80 s through injection drug use and sex, and nowadays HIV rates in Spain account for one of the largest in Europe. ...